Patent · US Active

Antibody and uses thereof

US7939642B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Fusion Antibodies Limited · IE

Inventors

Christopher Scott · Foxford, IE
Roberta Burden · Foxford, IE
Shane Olwill · Freising, DE
Brian Walker · New Philadelphia, US
Jim Johnston · Foxford, IE

Key dates

Filing date	Apr 10, 2006
Grant date	May 10, 2011
Priority date	—
Expiry date	Feb 6, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are specific binding members e.g. antibodies which may be used in the treatment of diseases associated with cathepsin S activity. The specific binding members binds cathepsin S and inhibits its proteolytic activity. The binding members may be used in the treatment of diseases such as cancer, inflammatory diseases, neurodegenerative disorders, autoimmune disorders, and other diseases associated with excessive, deregulated or inappropriate angiogenesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.